A5044304651- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Epilepsy research and treatment
- Cardiovascular Function and Risk Factors
- Ion channel regulation and function
- Cardiac Structural Anomalies and Repair
- Blood disorders and treatments
- Immunodeficiency and Autoimmune Disorders
- Cardiac Arrhythmias and Treatments
University Hospital Regensburg
2023-2024
Medizinische Hochschule Hannover
2024
Chronic heart failure may lead to chronic kidney disease. Previous studies suggest tubular markers N-acetyl-b-D-glucosaminidase (NAG) and Kidney-injury-molecule-1 (KIM-1) as potential for the cardiorenal syndrome (CRS). The prognostic value of NAG KIM-1 regarding implantable cardioverter defibrillator (ICD) shock therapies is unknown.We included 314 patients with an ICD collected plasma urine samples. Urine-values got related urinary creatinine. Outcomes interest were sustained adequate a...
Metamizole is a non-opioid ampyrone sulfonate compound with potent analgesic, antipyretic, and spasmolytic effects. Agranulocytosis rare life-threatening complication of metamizole. Here, we present the case 62-year-old patient who developed agranulocytosis as well hemolysis after single administration This illustrates inherent allergic potential metamizole its effects on different hematopoietic cell types.
Aim: NAG and KIM-1 as markers of tubular damage are suggested potential biomarkers for the cardiorenal syndrome. The aim study was to assess prognostic capability regarding progression chronic kidney disease (CKD) in patients with implantable cardioverter defibrillator (ICD). Materials & methods: We included 313 an ICD collected plasma urine samples. Follow-up performed after 51 months (interquartile range [IQR]: 25-55). outcome interest continuous CKD defined persistent decline estimated...